Long-term lithium-treated bipolar disorder patients are protected from leukocyte telomere shortening [28], and lithium carbonate therapy has been associated with improved kidney function through inhibition of GSK3beta activity and decreased senescence signaling in urinary exfoliated podocytes [29]. Here, GSK3B is linked to bipolar disorder.